Anthony J. Sinskey - 31 Mar 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Role
Director
Signature
Charles B. Haaser, attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 17:27:14 UTC
Previous filing
04 Jan 2023
Next filing
30 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Award $0 +1,415 +11% $0.000000 13,724 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $3,906 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the first quarter of 2023.